A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 27,797 shares of ABBV stock, worth $4.74 Million. This represents 2.92% of its overall portfolio holdings.

Number of Shares
27,797
Previous 27,779 0.06%
Holding current value
$4.74 Million
Previous $4.76 Million 15.22%
% of portfolio
2.92%
Previous 2.56%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $2,949 - $3,587
18 Added 0.06%
27,797 $5.49 Million
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $45,353 - $52,962
293 Added 1.07%
27,779 $4.76 Million
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $283,041 - $322,499
-1,771 Reduced 6.05%
27,486 $5.01 Million
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $45,270 - $50,985
329 Added 1.14%
29,257 $4.53 Million
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $34,733 - $40,209
260 Added 0.91%
28,928 $4.31 Million
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $41,740 - $51,943
315 Added 1.11%
28,668 $3.86 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $1,590 - $1,831
-11 Reduced 0.04%
28,353 $4.52 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $37,067 - $44,453
268 Added 0.95%
28,364 $4.59 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $65,226 - $74,809
486 Added 1.76%
28,096 $3.77 Million
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $8,257 - $10,497
60 Added 0.22%
27,610 $4.23 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $2,111 - $2,620
-16 Reduced 0.06%
27,550 $4.47 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $78,209 - $98,957
728 Added 2.71%
27,566 $3.73 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $129,276 - $146,747
1,215 Added 4.74%
26,838 $2.9 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $2.7 Million - $3 Million
25,623 New
25,623 $2.89 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cherry Creek Investment Advisors, Inc. Portfolio

Follow Cherry Creek Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.